In 2025, driven by regulatory upgrades and technological iterations, China's cosmetics industry is undergoing a profound transformation from "scale expansion" to "quality leapfrogging."

Data shows that in 2024, China's cosmetics retail sales reached 435.7 billion yuan, a year - on - year increase of 3.2%. Meanwhile, the functional skincare market size is expected to exceed 84.14 billion yuan, with a compound annual growth rate of 22.2%, far surpassing the industry average. At the core of this transformation are Chinese companies, which are leveraging hard - core technology and precise insights to continuously outperform international brands in the mass market while accelerating breakthroughs in the high - end sector.

I. Market Landscape: Domestic Brands Dominate the Mass Market, and Technology Breakthroughs in the High - End Sector

In the mass market, Chinese brands have achieved exponential growth in market share through a "component - focused + high - cost - performance" strategy. Data from 2025 shows that consumers aged 20 - 35 still contribute over 70% of domestic cosmetics consumption. Brands such as PROYA and Winona have topped the charts across multiple channels, including Tmall and Douyin.

Take KANS as an example. Its "makeup - and - nourishment - in - one" Red Man Yao essence saw a year - on - year sales surge of 412% in 2025. Thanks to its core ingredient, lysate of diploid yeast fermentation, it has become the top anti - aging product choice for Generation Z.

The high - end market is witnessing a new trend of "technological competition":

European and American brands dominate with their century - long technical accumulation, but Chinese brands are overtaking through synthetic biotechnology. Hyaluronic Acid Salicylic Acid Sodium, a new ingredient developed by Bloomage Biotech, has completed filing. Its "Super Hyaluronic Acid" technology triples the moisturizing effect, successfully entering the high - end anti - aging market.

II. Consumer Trends: Efficacy Verification and Personalized Needs Take Center Stage

Chinese consumers' demands for cosmetics have shifted from "emotional value" to "evidence - based efficacy."

New regulations in 2025 require all cosmetics to submit proof of efficacy claims, directly driving companies to increase R & D investment. The "Winona" Soothing Series by Botanee has passed 54 clinical tests, with a 92% efficacy rate for sensitive skin repair, becoming a recommended product by dermatology departments in hospitals. The explosion of the anti - aging market is particularly remarkable. Data shows that in 2025, China's anti - aging market size is expected to exceed 120 billion yuan, with 60% of consumers starting anti - aging care before the age of 25.

Personalized needs have given rise to the new track of "custom - made skin care."

The AI - based skin analysis system jointly developed by Shanghai Jahwa United, through 3D scanning and genetic testing, provides users with personalized skin - care solutions. The repurchase rate in its Tmall flagship store exceeds 45%. Bloomage Biotech's "Bio - Active" brand has launched a custom - made essence with a "morning C, evening A" formula, dynamically adjusting the ingredient ratio based on user skin type. It sold over a million bottles in its first month on the market.

III. Technological Revolution: AI - Empowered Innovation and Green Sustainability, AI technology is reshaping the logic of cosmetics R & D.

Beiersdorf leveraged AI to screen 50,000 ingredients and identified the brightening compound Thiamidol® 630, which inhibits tyrosinase activity with 10 times greater efficacy than conventional ingredients. Lubrizol's AI platform enables end-to-end intelligent processes from market insights to product evaluation, reducing R&D cycles by 40%. Chinese companies are also accelerating deployment, with Yusong Bio's high-throughput screening platform integrating machine learning to successfully develop targeted anti-wrinkle peptide ingredients.

IV. Regulatory Upgrades: Full - Chain Risk Prevention and Strict Efficacy Management

In 2025, cosmetics regulation has entered a "precision" phase.

The National Medical Products Administration (NMPA) has issued the Measures for the Administration of Cosmetics Safety Risk Monitoring and Evaluation, focusing on monitoring children's cosmetics and banned ingredients. The Beijing Municipal Drug Administration has issued guidelines for advertising publication, explicitly prohibiting exaggerated publicity. Watsons was fined 30,000 yuan for false advertising. Efficacy evaluation has become a must - have for companies. Data from the National Engineering Research Center for Genetic Engineering Drugs shows that the demand for efficacy testing increased by 120% in the first half of 2025 compared to the previous year.

V. International Competition: Domestic Brands Going Global and Local Brands' Counterattack

Chinese brands' going - global efforts have entered a new "high - end" phase.

Florasis's flagship store in Ginza, Tokyo achieved first-day sales exceeding 1.5 million yuan (approx. $208,000 USD). Its "Oriental Beauty" concept resonated with Japanese consumers, driving a repurchase rate of 38%. Proya launched a pop-up store in Paris, where its "Ruby Cream," powered by hexapeptide technology, secured a spot in Europe's top 10 anti-aging product rankings. In contrast, international giants like L'Oréal and Shiseido are accelerating localized R&D. L'Oréal's Shanghai R&D center launched a "China-Exclusive" anti-blue light serum in 2025, though its market reception has been lukewarm.

From Manufacturing Hub to Tech Powerhouse

In 2025, China's cosmetics industry is reshaping the global landscape through a dual engine of "Technology + Culture." As Bloomage Biotech's synthetic biology breakthroughs challenge international ingredient monopolies, and Proya's "Double Anti" (Anti-oxidation & Anti-glycation) series redefines anti-aging standards, Chinese brands have pivoted from being "value-for-money alternatives" to becoming "technology leaders."

Looking ahead, with the continued expansion of the functional skincare market (expected to reach 150 billion yuan by 2027) and the deepening of overseas strategies, China is poised to become a global source of cosmetics innovation. This transformation is not only a victory in commercial competition but also a dual demonstration of China's technological confidence and cultural soft power.